HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway
| Image |  |
|---|---|
| Description | scientific article published on 4 October 2016 |
| Author/s |
author: Cecilia Lanzi Alessandro Pini |
| Publication date | October 4, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |